Who makes E coli Vaccine 5 Dose B?

E coli Vaccine 5 Dose B is developed by Pfizer Inc..

What development phase is E coli Vaccine 5 Dose B in?

E coli Vaccine 5 Dose B is FDA-approved (marketed).

What is the generic name of E coli Vaccine 5 Dose B?

e-coli-vaccine-5-dose-b is the generic (nonproprietary) name of E coli Vaccine 5 Dose B.

Last reviewed 2026-05-14 · How we verify

E coli Vaccine 5 Dose B (e-coli-vaccine-5-dose-b)

Pfizer Inc. · FDA-approved active Vaccine Quality 3/100

At a glance

Generic name	e-coli-vaccine-5-dose-b
Sponsor	Pfizer Inc.
Modality	Vaccine
Therapeutic area	Infectious Disease
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Learn About a Vaccine Against E Coli in Healthy Adults (PHASE1)
Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

E coli Vaccine 5 Dose B CI brief — competitive landscape report
E coli Vaccine 5 Dose B updates RSS · CI watch RSS
Pfizer Inc. portfolio CI